SUGGESTED GUIDELINES FOR THE USE OF TACROLIMUS IN PEDIATRIC LIVER TRANSPLANT PATIENTS
- 1 March 1996
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 61 (5) , 847,848-8
- https://doi.org/10.1097/00007890-199603150-00033
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Comparative evaluation of tacrolimus (Fk506) and cyclosporin a as immunosuppressive agentsTransplantation Reviews, 1995
- AN INCREASED INCIDENCE OF EPSTEIN-BARR VIRUS INFECTION AND LYMPHOPROLIFERATIVE DISORDER IN YOUNG CHILDREN ON FK506 AFTER LIVER TRANSPLANTATION1Transplantation, 1995
- VIRAL AND IMMUNOLOGIC ASPECTS OF EPSTEIN-BARR VIRUS INFECTION IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS1Transplantation, 1995
- FK506 CONVERSION THERAPY IN PEDIATRIC LIVER TRANSPLANTATIONTransplantation, 1994
- Lymphoproliferative disorder in a liver transplant patient on FK 506The Lancet, 1991